199 reports of this reaction
1.6% of all LORATADINE AND PSEUDOEPHEDRINE SULFATE reports
#12 most reported adverse reaction
PALPITATIONS is the #12 most commonly reported adverse reaction for LORATADINE AND PSEUDOEPHEDRINE SULFATE, manufactured by Bayer HealthCare LLC.. There are 199 FDA adverse event reports linking LORATADINE AND PSEUDOEPHEDRINE SULFATE to PALPITATIONS. This represents approximately 1.6% of all 12,600 adverse event reports for this drug.
Patients taking LORATADINE AND PSEUDOEPHEDRINE SULFATE who experience palpitations should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PALPITATIONS is a less commonly reported adverse event for LORATADINE AND PSEUDOEPHEDRINE SULFATE, but still significant enough to appear in the safety profile.
In addition to palpitations, the following adverse reactions have been reported for LORATADINE AND PSEUDOEPHEDRINE SULFATE:
The following drugs have also been linked to palpitations in FDA adverse event reports:
PALPITATIONS has been reported as an adverse event in 199 FDA reports for LORATADINE AND PSEUDOEPHEDRINE SULFATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
PALPITATIONS accounts for approximately 1.6% of all adverse event reports for LORATADINE AND PSEUDOEPHEDRINE SULFATE, making it a notable side effect.
If you experience palpitations while taking LORATADINE AND PSEUDOEPHEDRINE SULFATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.